01 42Care4 Aps
02 15Abacus Medicine A/S
03 1Amryt Pharmaceuticals Dac
04 4BIOINDUSTRIA L.I.M. SpA
05 1BIOINDUSTRY ITALIAN LABORATORY MEDICINALI SPA
06 3CHEMI SPA
07 3CHEMI SpA
08 4Campus Pharma Ab
09 1Cc Pharma Nordic Aps
10 9Cross Pharma Ab
11 3Ebb Medical Ab
12 1Farmak JSC
13 3Fresenius Kabi Ab
14 3Gp Pharm
15 4Gp Pharm Sa
16 4HOSPIRA ITALIA Srl
17 4Hospira UK Limited
18 7ITALFARMACO SpA
19 3LIFEPHARMA SPA
20 3LIFEPHARMA SpA
21 4Labatec Pharma Sa
22 1Lyomark Pharma Gmbh
23 15Medartuum Ab
24 3Mepha Pharma Ag
25 3Northern Medical Group Aps
26 6Novartis Pharma Schweiz Ag
27 6Novartis Pharmaceuticals Sa
28 7Novartis Sweden Ab
29 1Orifarm AS
30 12Orifarm Ab
31 7Paranova Pharmaceuticals Ab
32 4Pfizer Ab
33 2Pfizer Sl
34 3Ratiopharm Espana Sa
35 4SUN PHARMACEUTICAL IND. BV
36 4SUN PHARMACEUTICAL IND.EU.B.V.
37 4Sun Pharmaceutical - Netherlands
38 4Sun Pharmaceutical Industries (Europe) Bv
39 4Sun Pharmaceutical Industries Europe Bv
40 6Teva Bv
41 2Teva Sweden Ab
42 3The Fresenius Kabi Norge AS - Halden
43 2Uab Bijon Medica
01 73Octreotide
02 114Octreotide Acetate
01 1Capsule
02 3Injectable And Infusion Solution
03 3Injectable And Perfusion Solution
04 57Injectable Solution
05 11Injection fluid, resolution
06 1Octreotide 0.05Mg 10 Units Parenteral Use
07 1Octreotide 0.1Mg 10 Units Parenteral Use
08 1Octreotide 0.5Mg 10 Units Parenteral Use
09 1Octreotide 0.5Mg 3 Units' Parenteral Use
10 5Octreotide 100Mcg 5 Units Parenteral Use
11 1Octreotide 10Mg 1 Unit Parenteral Use
12 4Octreotide 1Mg 1 Unit Parenteral Use
13 1Octreotide 20Mg 1 Unit Parenteral Use
14 1Octreotide 30Mg 1 Unit Parenteral Use
15 4Octreotide 500Mcg 5 Units Parenteral Use
16 5Octreotide 50Mcg 5 Units Parenteral Use
17 3Powder And Solvent For Injectable Suspension
18 6Powder And Solvent For Prolonged-Release Injectable Suspension
19 31Powder For Injection
20 1Powder and liquid to the injection fluid, suspension
21 1Solution
22 27Solution For Injection
23 5Solution For Injection In Pre-Filled
24 1Solution For Injection In Pre-Filled Syringe
25 1Solution For Injection Or Concentrate For Solution For Infusion
26 10Solution For Injection/Infusion
27 1Solution for Injection
01 36Italy
02 12Norway
03 22Spain
04 103Sweden
05 13Switzerland
06 1Ukraine
01 4Longastatina
02 3Longastatina Lar
03 1Mycapssa
04 1OCTREOTIDE BIOINDUSTRY LIM
05 4OCTREOTIDE SUN
06 1Octra
07 4Octreotida Gp-Pharm
08 2Octreotida Hospira
09 3Octreotida Ratiopharm
10 4Octreotida Sun
11 3Octreotida Teva
12 12Octreotide
13 3Octreotide 2Care4
14 3Octreotide Abacus Medicine
15 2Octreotide Bijon
16 4Octreotide Campus
17 3Octreotide Csc
18 6Octreotide Fresenius Kabi
19 8Octreotide Hospira
20 4Octreotide Labatec
21 2Octreotide Orifarm
22 4Octreotide Sun
23 6Octreotide Teva
24 3Octreotide-Mepha LA
25 1Octroflex
26 4Oktreotid SUN
27 3SIROCTID
28 42Sandostatin
29 1Sandostatin ALLOWS
30 3Sandostatin LAR Fertigspritzen
31 31Sandostatin Lar
32 3Sandostatina
33 3Siroctid
34 3TREOJECT
35 3Treoject
Regulatory Info :
Registration Country : Italy
Brand Name : Siroctid
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes 1 ml 0. 1 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Siroctid
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes 1 ml 0.05 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.1 mg/1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.05 mg/1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Longastatina
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.1 mg 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Longastatina
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.05 mg 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.1 mg/1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.05 mg 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Treoject
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes EV SC 1 ml 0. 1 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Treoject
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes EV SC 1 ml 0.05 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
